Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ · Technology
Cure Pharmaceutical Holding Corp. Revenue 2023–2024
Cure Pharmaceutical Holding Corp. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cure Pharmaceutical Holding Corp. revenue for the quarter ending March 31, 2025 was 10.1 M, a 23.26% decrease year-over-year.
- Cure Pharmaceutical Holding Corp. revenue for the twelve months ending March 31, 2025 was 47.2 M.
- Cure Pharmaceutical Holding Corp. annual revenue for 2024 was 46.4 M, a 12.81% decrease from 2023.
- Cure Pharmaceutical Holding Corp. annual revenue for 2023 was 53.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cure Pharmaceutical Holding Corp. Earnings — FAQ
Cure Pharmaceutical Holding Corp. (CURR) earnings over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CURR's earnings history?
The chart and table above show Cure Pharmaceutical Holding Corp.'s earnings by year and by quarter, including the growth rate.